Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Could Makary Face Facility Issues As US FDA Commissioner?
Mar 07 2025
•
By
Sue Sutter
,
Derrick Gingery
, and
Nancy Pham
The FDA's real property footprint could shrink under the second Trump Administration.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Geography